Loading
MicroPort CardioFlow Medtech Corporation - B Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by Zhang Ruinian, was filed 27 Apr 2026.
MicroPort CardioFlow Medtech Corporation - B: what insiders have been doing
MicroPort CardioFlow Medtech Corporation - B belongs to the Health Care sector. Filings by its managers are published through HKEX. Between 22 October 2025 and 22 October 2026, 2 insiders published 5 filings.
Purchases and sales both appear in the filings: 1 purchase (1 insider) and 3 sales (1 insider, €346k). The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Among those who bought: 1 senior executive. Wanstok Philippe filed the largest sale, €121k, on 12 May 2026, which represents 0.065% of the company's market value.
The last purchase on record was published on 27 April 2026, which is 180 days ago. The median gap between a trade and its publication by HKEX is 20 days. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Compared with its exchange (1,314 companies, median 4 filings), a count of 5 filings is above the norm. Our records for MicroPort CardioFlow Medtech Corporation - B go back to 2021, with 34 purchases and 3 sales on the open market in total.
Elsewhere in the same sector, our signals recently picked up insider purchases at UCB. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Insider Decl.
40
Thresholds
n/a
Buy Volume
€8,480
34 ops. · all time
Sell Volume
€345,612
3 ops. · all time
Who traded when
BuySaleWanstok Philippe3 sales
Zhang Ruinian3 buys
Yan Luying2 buys
Zhao Liang2 buys
Since the insiders bought
- -53.8%Entry HK$2.47 · Close at T+90 HK$1.14
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 20,435 of 26,286 companies
32.4
score / 100
Value28
Quality37
FCF yld-2.3%
Earn yld-1.2%
EV/EBITDA·
ROE-6.7%
Gross mgn65%
Net mgn-33%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$1.28
Analyst consensus
2 analysts1.00/5
HK$6.26Target HK$6.93(+441%)HK$7.60
Income statement
RevenueHK$57M
Gross profitHK$37.1M65% margin
EBITDA-HK$2.2M-4% margin
Net income-HK$18.8M-33.0% margin
Valuation
P/Book0.8x
Beta0.27
Balance sheet & cash
Market capHK$1.6B
Total debtHK$232.2M
Free Cash Flow-HK$38.3M
Debt / Equity91%
Profitability & ownership
ROE-6.7%
ROA-2.4%
% insiders49.0%
% institutions21.0%
Last declaration on 15 May 2026
Declarations40 total
400,000 shares@ HK$2.5910.060% mcap32.7% of flowShareXHKGHKEX:DA20260515E00004
400,000 shares@ HK$2.77970.065% mcap35.1% of flowShareXHKGHKEX:DA20260511E00419
339,000 shares@ HK$3.01960.059% mcap32.2% of flowShareXHKGHKEX:DA20260508E00632
143,920 sharesShareXHKGHKEX:DA20260426E00009
Canonical exit: 29 Jun 2026 (T+90)
18,523,140 sharesShareXHKGHKEX:DA20251231E00491
90,000 shares@ HK$0.823100.0% of flowShareXHKGHKEX:DA20250411E00062
Canonical exit: 9 Jul 2025 (T+90)
606,701 sharesShareXHKGHKEX:DA20250402E00496
Canonical exit: 26 Jun 2025 (T+90)
1,213,402 sharesShareXHKGHKEX:DA20250402E00495
Canonical exit: 26 Jun 2025 (T+90)
2,000,000 sharesShareXHKGHKEX:DA20250402E00491
Canonical exit: 26 Jun 2025 (T+90)
303,350 sharesShareXHKGHKEX:DA20250402E00494
Canonical exit: 26 Jun 2025 (T+90)
606,700 sharesShareXHKGHKEX:DA20250402E00493
Canonical exit: 26 Jun 2025 (T+90)
872,428 sharesShareXHKGHKEX:DA20240412E00577
Canonical exit: 7 Jul 2024 (T+90)
436,214 sharesShareXHKGHKEX:DA20240412E00576
Canonical exit: 7 Jul 2024 (T+90)
938,008 sharesShareXHKGHKEX:DA20240412E00575
Canonical exit: 7 Jul 2024 (T+90)
1,876,016 sharesShareXHKGHKEX:DA20240412E00574
Canonical exit: 7 Jul 2024 (T+90)
4,000,000 sharesShareXHKGHKEX:DA20230901E00283
Canonical exit: 28 Nov 2023 (T+90)
2,000,000 sharesShareXHKGHKEX:DA20230901E00282
1,209,992 sharesShareXHKGHKEX:DA20230713E00335
Canonical exit: 9 Oct 2023 (T+90)
391,499 sharesShareXHKGHKEX:DA20230713E00331
Canonical exit: 9 Oct 2023 (T+90)
1,624,933 sharesShareXHKGHKEX:DA20230713E00321
Canonical exit: 9 Oct 2023 (T+90)
1,105,146 sharesShareXHKGHKEX:DA20230404E00498
Canonical exit: 28 Jun 2023 (T+90)
355,146 sharesShareXHKGHKEX:DA20230404E00497
Canonical exit: 28 Jun 2023 (T+90)
410,300 sharesShareXHKGHKEX:DA20230404E00503
Canonical exit: 28 Jun 2023 (T+90)
410,300 sharesShareXHKGHKEX:DA20230404E00502
Canonical exit: 28 Jun 2023 (T+90)
449,683 sharesShareXHKGHKEX:DA20230404E00519
Canonical exit: 28 Jun 2023 (T+90)
25 of 40 declarations
About MicroPort CardioFlow Medtech Corporation - B
MicroPort CardioFlow Medtech Corporation - B is a company focused on developing medical technologies for the treatment of cardiovascular diseases. It is listed on the Hong Kong Stock Exchange, XHKG.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
